CME Group announced that its board of directors has authorised ashare buyback program of up to $1.1 billion of CME Group Class A commonstock, subject to market conditions, and other initiatives. The buyback program will take place over a period of up to 18 months. The board’s authorisation permits the repurchase of shares through the open market, an accelerated program, a tender offer or privately negotiated transactions.
In addition, CME Group intends to declare a special dividend of $5.00 percommon share, following the resolution of the company’s pending NYMEX transaction.
“The board’s authorization to institute a share buyback program represents an efficient use of our capital and demonstrates continued confidence in CME Group’s strategy and growth potential,” says CME Group executive chairman Terry Duffy. “We recognise that our successful merger with the Chicago Board of Trade and our continued growth and success will result in significant free cash flow generation that will exceed what we need to have on hand in order to continue our aggressive global growth strategy. The combination of a flexible share buyback program and a special dividend addresses the different interests and preferences of our diverse shareholder base.”
“With the completion of the merger with CBOT and the pending acquisition ofNYMEX, our need to significantly build cash balances has changed,” says CMEGroup CEO Craig Donohue. “Today’s initiatives positively address the interests of our shareholders, while allowing us to successfully complete our pending acquisition of NYMEX in a highly disciplined fashion. CME Group will continue to take advantage of the many growth opportunities we are pursuing globally through product innovation, increased distribution, over- the-counter initiatives, and additional strategic partnerships such asour agreement with BM&F Bovespa.”
“We believe our new capital structure initiatives reflect the high operating efficiency and relatively low capital requirements inherent in our business model,” says CME Group CFO Jamie Parisi. “We will incurup to $4 billion of debt initially to execute both the NYMEX transaction and this return of capital. We are balancing the shareholder benefits ofincurring some debt with the critical role CME Group plays in global capital markets and we are, therefore, targeting a very strong investment grade credit rating.”
Under SEC rules, CME Group will not be able to repurchase shares duringcertain restricted time periods. The share repurchase plan does not obligate CME Group to repurchase any specific dollar amount or number of shares of its Class A common stock. CME Group intends to conduct any such repurchases in compliance with the applicable provisions of Rules 10b-5 and 10b-18 and Regulation M of the Securities Exchange Act of 1934, as amended, and any other applicable laws and regulations.